आपल्याला अधिक आत्मविश्वासाने गुंतवणूक करण्यात मदत करण्यासाठी तपशीलवार आयपीओ पुनरावलोकने, क्षेत्र विश्लेषण आणि शैक्षणिक मार्गदर्शक एक्सप्लोर करा.
Check the latest upcoming IPOs in India, including SRIT India, Shah Investor's Home, Vishal Nirmiti, Nityas Gems and 16 SME IPOs. Get price bands, issue sizes, dates and GMP updates.
Symbiotec Pharmalab IPO entered Day 2 on August 25, 2026, and crossed full subscription in morning bidding. The ₹1,757 crore mainboard IPO is priced at ₹938–₹988 per share and comprises a ₹150 crore fresh issue with a ₹1,607 crore OFS. Latest grey-market indications suggest roughly 34% potential premium, although GMP has cooled from opening-day levels. The pharmaceutical CDMO reported FY2026 revenue of ₹869.1 crore and PAT of ₹109.9 crore, while ₹112.5 crore of fresh proceeds is planned for debt repayment. Investors are now watching subscription momentum, product concentration and the sustainability of the company's export-led API business.
Hy-Tech Engineers IPO entered its second bidding day on August 25, 2026, with strong investor interest. The ₹135.73 crore mainboard issue is priced at ₹50–₹53 per share and comprises a ₹60 crore fresh issue and ₹75.73 crore OFS. By around 11 AM today, the IPO was subscribed about 11.21 times, led by retail and NII investors. The latest reported GMP has risen to ₹30, indicating an unofficial premium of around 56.6% over the upper price band. The hydraulic fittings manufacturer plans to use fresh proceeds mainly for machinery expansion and debt repayment.
Augmont Enterprises IPO closes today, August 25, 2026, after attracting strong investor demand for its ₹825 crore mainboard offering. The IPO is priced at ₹750–₹788 per share and includes a ₹620 crore fresh issue plus ₹205 crore OFS. Augmont operates an integrated gold and silver platform spanning bullion procurement, refining, B2B trading, digital gold and consumer offerings across India. Latest grey-market reports indicate a premium of around 41–42%, while subscription has risen sharply on the final bidding day. With ₹465 crore of fresh proceeds planned for working-capital requirements, investors will now focus on allotment, listing performance, margins and cash-flow efficiency.
Shanti Inorganics IPO will open on August 31, 2026, and close on September 2 at a price band of ₹79–₹83 per share. The Gujarat-based specialty chemical manufacturer produces sulphur-based inorganic chemicals and is expanding manufacturing capacity at its Bavla facility. The company reported FY2026 revenue of about ₹71.22 crore and PAT of ₹10.22 crore, followed by ₹15.98 crore revenue and ₹2.50 crore PAT during the first two months of FY2027. With major capacity expansion planned, investors will be watching utilisation, margins, raw-material costs and execution after the NSE SME listing.
Paluck Technologies IPO will open on August 28, 2026, and close on September 1 at a price band of ₹46–₹48 per share. The BSE SME issue aims to raise about ₹33 crore and is structured as a fresh issue. Paluck Technologies has evolved from a diesel-generator service provider into an engineering and infrastructure company with activities including ready-mix concrete and equipment-related services. For the 11 months ended February 2026, total income reached ₹105.09 crore while PAT increased to ₹13.84 crore. IPO proceeds will support new RMC machinery and DG sets, working capital and debt repayment, making capacity utilisation and cash-flow growth important factors after listing.
Augmont Enterprises IPO is open from August 21 to August 25, 2026, at a price band of ₹750–₹788 per share. The ₹825 crore mainboard issue includes ₹620 crore of fresh shares and a ₹205 crore OFS. The integrated gold and silver platform serves both businesses and consumers through bullion, refining, digital gold, jewellery and related precious-metal services. With Day 2 subscription at 2.74 times and GMP rising close to 50%, investors are watching its rapid growth, large working-capital requirement and ability to convert scale into stronger cash flows.
Skyways Air Services IPO opened today, August 24, 2026, at a price band of ₹131–₹138 per share. The ₹582.80 crore mainboard issue comprises a ₹398.80 crore fresh issue and ₹184 crore OFS. The logistics company has ranked No. 1 among Indian air-freight forwarders by airway bills for four consecutive years and generated over 77% of FY2026 revenue from air freight. With IPO funds planned for debt repayment and working capital, investors will be watching its freight volumes, margins, global trade exposure and cash-flow efficiency.
Hy-Tech Engineers IPO opened today, August 24, 2026, at a price band of ₹50–₹53 per share. The ₹135.73 crore mainboard issue combines a ₹60 crore fresh issue with an OFS worth about ₹75.73 crore. The Maharashtra-based engineering company manufactures hydraulic fittings with more than 11,000 SKUs for construction machinery, automobiles, agricultural equipment and other industrial applications. With FY2026 PAT at ₹22.59 crore and IPO proceeds planned for capacity expansion and debt repayment, investors will be watching its manufacturing growth, customer concentration and working-capital efficiency.
Symbiotec Pharmalab IPO opened today, August 24, 2026, at a price band of ₹938–₹988 per share. The ₹1,757 crore mainboard issue combines a ₹150 crore fresh issue with a large ₹1,607 crore OFS. The Indore-based pharmaceutical manufacturer specialises in steroid and other niche APIs, with more than two-thirds of revenue generated internationally. With GMP indicating roughly 35–41% premium on opening day, investors are closely watching its export strength, product concentration, debt repayment and valuation.
